Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Diagnostics
AI/Digital
Diagnostics
Biological age test to steer GLP-1 prescriptions
Diagnostics
Mito adds a $249 heart scan. Who needs one?
Diagnostics
UK’s Alzheimer’s diagnosis gap gets a new fix
A new partnership is combining a blood test, a cognitive app and national infrastructure to cut
Diagnostics
Two very different Alzheimer’s tests just teamed up
Diagnostics
Ecosystem
Younger contest puts aging clocks to the test
AI/Digital
Diagnostics
Ecosystem
AliveCor launches $0 Medicare health program
AI/Digital
Diagnostics
AI tool spots hidden heart attacks, FDA says yes
AI/Digital
Diagnostics
The blood pressure cuff may be on borrowed time
Diagnostics
Can we make the brain age backwards?
AI/Digital
Diagnostics
Apple Watch can now estimate your ‘health age’
Diagnostics
Mito Health passes 1 million lab tests, expands beyond longevity
Diagnostics
FDA clears C2N Diagnostics’ first blood test for early Alzheimer’s
AI/Digital
Diagnostics
ŌURA defends its sleep science amid class-action lawsuit
Diagnostics
Handheld heart monitor doubles arrhythmia catches
AI/Digital
Clinics
Diagnostics
Neko Health body scan lands in NYC with 25K on the waitlist
Diagnostics
Research
Forget memory tests: Could sleep catch Alzheimer’s first?
Diagnostics
Ecosystem
Biograph builds dedicated women’s preventive health arm
Diagnostics
Amprion expands Parkinson’s test to Europe
AI/Digital
Diagnostics
FDA clears software that quantifies amyloid in Alzheimer’s
Diagnostics
Function, NYU take aim at disease before diagnosis
Diagnostics
Claremedica’s digital test finds 90% of new dementia cases early
Diagnostics
Building a health system that puts prevention first
Diagnostics
Quest, Humanity bring biological age test to 2,000 US locations
Diagnostics
Whole-body MRI is leaving the biohacker bubble
Diagnostics
Ecosystem
What the body’s early warning system is really telling us
Diagnostics
Ecosystem
What can skin tell us about how we age?
Diagnostics
Investment
Investment
Supplements
Decode Age advances longevity pipeline after $1.7m raise
AI/Digital
Diagnostics
Longevity AI taps real-world data for disease risk prevention
Diagnostics
Whole genome sequencing for $599? Human Longevity bets big
Diagnostics
Ecosystem
Features
‘Aging clocks are tools – not verdicts’
AI/Digital
Diagnostics
The next longevity clinic may already be in your bathroom
AI/Digital
Diagnostics
AI brain care: Viz.ai moves into brain aging with Cortechs.ai deal
AI/Digital
Diagnostics
The next frontier in Alzheimer’s trials? Sleep
Diagnostics
Hilo aims to make blood pressure a daily habit
Diagnostics
Investment
Investment
Amprion lands funding to expand brain disease testing
Diagnostics
Alamar’s blood test breakthrough targets key Alzheimer’s marker
Diagnostics
Startup Juno Bio raises $3.8m for smarter women’s diagnostics
AI/Digital
Diagnostics
Dumbo Health builds a new longevity model for sleep
Diagnostics
Research
Cumulus’ at-home Alzheimer’s testing clears hurdle
Diagnostics
Generation Lab tailors biological age testing by sex
Diagnostics
Investment
Investment
Aptorum-backed DiamiR expands Alzheimer’s diagnostic efforts
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report